Navigation Links
Global Next Generation Sequencing Market 2012-2016
Date:10/19/2013

NEW YORK, Oct. 17, 2013 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

 

Global Next Generation Sequencing Market 2012-2016

http://www.reportlinker.com/p01698925/Global-Next-Generation-Sequencing-Market-2012-2016.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Genomics

 

TechNavio's analysts forecast the Global Next Generation Sequencing market to grow at a CAGR of 20.78 percent over the period 2012-2016. One of the key factors contributing to this market growth is the increased adoption of next generation sequencing by new customers. The Global Next Generation Sequencing market has also been witnessing an introduction of new DNA sequencing products and accessories. However, the logistical problems could pose a challenge to the growth of this market.

 

TechNavio's report, Global Next Generation Sequencing Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market in the Americas, and the EMEA and APAC regions; it also covers the Global Next Generation Sequencing market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

 

The key vendors dominating this market space are Illumina Inc., Life Technologies Corp., Roche Holding AG, and Pacific Biosciences of California Inc.

 

The other vendors mentioned in the report are 23andMe Inc., Ambry Genetics Corp., Axeq Technologies Inc., Beijing Genomics Institute, GeneDx, Fluidigm Corp., Foundation Medicine Inc., Good Start Genetics Inc., Helicos BioSciences Corp., Knome Inc., NABsys Inc., O
'/>"/>

SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related biology news :

1. Novo Nordisk and BGI establish global collaboration framework
2. EU-funded study underlines importance of Congo Basin for global climate and biodiversity
3. Global warming threat to coral reefs: Can some species adapt?
4. 1 solution to global overfishing found
5. Young researcher taking fight against global killer to the next level in Vietnam
6. Heightened Security Threats and Economic Issues Provide Fillip to Global Civil and Military Biometrics Market, Says Frost & Sullivan
7. Global Information Inc. Announces Discounted Conference Registration For Bio-IT World Asia and Biodetection Technologies 2012
8. Global effort launched to save turtles from extinction
9. New Biotech and Pharmaceutical Market Research from Global Information Inc Forecasts Strong Growth Coming Out of Recession
10. 2012 Forecast for US Molecular Diagnostics Market Now Available From Global Information Inc.
11. Desert to Rainforest global classroom links future teachers, classrooms in Phoenix and Panama
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/11/2015)... , May 11, 2015 Curemark LLC, ... the start of a new Phase III double blind, ... its novel formulation, CM-AT, on all children ages 3-8 ... its FDA Phase III double blinded clinical trial for ... low levels of the digestive enzyme chymotrypsin. This new ...
(Date:5/5/2015)... 2015, NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" ... growing mobile commerce market, reminds investors and media that  Mr. ... presenting  at CARTES SECURE CONNEXIONS AMERICA 2015, held in ... The three-day conference is organized into a series of ... themed Global Fraud: Where is the Trust in Cyberspace? ...
(Date:4/20/2015)... , April 20, 2015 Huntington Memorial ... Valley to implant a new miniaturized, wireless monitoring sensor ... is the first and only FDA-approved heart failure monitoring ... admissions when used by physicians to manage heart failure. ... that is implanted in the pulmonary artery (PA) during ...
Breaking Biology News(10 mins):Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 2NXT-ID, Inc.'s CTO, David Tunnell, Presents at CARTES SECURE CONNEXIONS AMERICA 2015 Today in Washington DC. 3Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 2Huntington Memorial Hospital Becomes First in the San Gabriel Valley to Offer Patients a New Heart Failure Monitoring Solution 3
... University provides molecular-level insights into how cellulose the ... structural component of plant cell walls breaks down ... into any number of useful products, including liquid transportation ... Using a supercomputer that can perform functions thousands of ...
... Ridge, Ill. (December 14, 2012) It is estimated ... prevalent condition known as metabolic syndrome which is a ... factors: large waistline, high triglycerides, low HDL cholesterol, high ... a variety of risk factors that increase the likelihood ...
... 13, 2012 Swift Charities, the charitable arm of ... Fund for Diabetes Research at the Translational Genomics Research ... The Waylon Fund was Swift,s "charity of choice." ... as well as matching contributions from Phoenix-based Swift, were ...
Cached Biology News:Study fuels insight into conversion of wood to bio-oil 2Use 'em, don't lose 'em! Eating egg yolks adds nutritious benefits 2Use 'em, don't lose 'em! Eating egg yolks adds nutritious benefits 3Swift Transportation donates more than $15,000 to the Waylon Fund 2
(Date:6/2/2015)... , June 2, 2015 GOJO, inventors ... its commitment to antibiotic stewardship at the White House ... and animal health organizations and stakeholders at the White ... years to slow the emergence of antibiotic-resistant bacteria, detect ... and prevent the spread of resistant infections. ...
(Date:6/2/2015)... CA (PRWEB) June 02, 2015 German-based ... official United States distributor for the Moenninghoff product ... stated, “I am pleased to announce that the R.M. ... market. For our firm, founded in 1916, this is ... R.M. Hoffman is the kind of professional distributor we ...
(Date:6/1/2015)...  Turing Pharmaceuticals AG announced that life sciences executive ... MSc,  has joined the company as president of ... holds a medical degree as well as a ... accomplishments in the pharmaceutical industry, and extensive clinical ... played a leadership role in numerous programs for ...
(Date:6/1/2015)... CHICAGO and RARITAN, N.J. ... & Development, LLC (Janssen) announced data from the ... significant improvement in progression-free survival (PFS) with trabectedin ... with advanced liposarcoma (LPS) or leiomyosarcoma (LMS) previously ... additional chemotherapy regimen. SAR3007 is the largest randomized ...
Breaking Biology Technology:GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 2GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 3GOJO Among Leaders At The White House Forum On Antibiotic Stewardship 4R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 2R.M. Hoffman Company designated official United States distributor for the Moenninghoff product line. 3Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 2Turing Pharmaceuticals Names Eliseo Salinas, MD and MSc, President of Research and Development 3Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 2Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 3Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 4Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 5Trabectedin Improves Disease Control in Patients with Advanced Soft Tissue Sarcoma 6
... Simple Steps Can Make a Big Difference in Managing ... As this year,s spring nasal allergy season quickly ... to manage their symptoms and ward-off allergens before they ... nasal allergy sufferers prepare for the spring nasal allergy ...
... 2 Epistem Plc,(LSE:EHP) the UK biotechnology and ... a research and development collaboration with Novartis,to identify ... of disease,areas. , The ... programme, with Novartis,s insights into disease pathways &,bioinformatics. ...
... 2 /PRNewswire-Asia/ -- Simcere Pharmaceutical Group,(NYSE: ... branded generic,pharmaceuticals and innovative anti-cancer pharmaceuticals in the ... to release its 2008,fourth quarter and full year ... opens in the United States. Simcere,s chief executive ...
Cached Biology Technology:Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin' 2Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin' 3Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin' 4Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin' 5Video: Experts Unite to Help People Manage Spring Nasal Allergy Sneezin' 6Epistem Announces Research and Development Collaboration With a Major Pharmaceutical Company 2Simcere Pharmaceutical Group to Announce 2008 Fourth Quarter and Full Year Earnings On Thursday, March 12, 2009 2
... Express Cloning Checker Kits provide two highly ... transformation without time-consuming plasmid preparation. By using ... all you need to do is to ... directly from the transformation plates into the ...
Recombinant Equine IL-4, CF...
DALT GRADIENT MAKER,230V, 1 EA. Category: 2D DALT Systems....
delta-like 1 homolog (Drosophila)...
Biology Products: